Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in PCRX — Pacira BioSciences, Inc.

CIK 902219 Boston, MA
Back to PCRX Full portfolio

Position in PCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,294,928
+$3,483,474 QoQ
Shares Held
563,458
+17.8% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 254 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 0% Shared 92% None 8%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. PCRX ranks #10 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,379,025 $747,197,111
2 ZTS
Zoetis Inc.
 9,423,895 $677,201,094
3 TEVA
Teva Pharmaceutical Industries Ltd
 7,671,157 $259,898,795
4 ALKS
Alkermes plc.
 2,814,804 $147,495,727
5 LNTH
Lantheus Holdings, Inc.
 1,013,063 $112,389,207
6 ELAN
Elanco Animal Health Inc
 2,676,050 $65,857,589
7 HLN
Haleon plc
 3,273,583 $30,542,527
8 XERS
Xeris Biopharma Holdings, Inc.
 2,365,103 $18,731,613

All Filings in PCRX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,294,928 563,458
2026-03-31 $10,811,454 478,383
2025-12-31 $13,419,736 518,537
2025-09-30 $13,619,830 528,515
2025-06-30 $13,039,884 545,602
2025-03-31 $13,347,679 537,130
2024-12-31 $8,858,397 470,191
2024-09-30 $6,842,465 454,649
2024-06-30 $13,936,929 487,135
2024-03-31 $8,568,237 293,232
2023-12-31 $11,053,425 327,606
2023-09-30 $9,630,758 313,910
2023-06-30 $17,524,613 437,350
2023-03-31 $15,457,927 378,778
2022-12-31 $25,600,822 663,062
2022-09-30 $50,906,445 957,068
2022-06-30 $43,316,258 742,989
2022-03-31 $51,620,176 676,365
2021-12-31 $4,271,769 70,995
2020-12-31 $21,905,688 366,071
2020-09-30 $22,464,078 373,654
2020-06-30 $19,650,539 374,510